BIBLIOGRAPHIC RECORD

Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Raffa RB
Source of metadata
PubMed
Year recorded
2026

Public identifiers and source

Open the source record

Reference

Raffa RB. (2026). Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan. https://pubmed.ncbi.nlm.nih.gov/42733721/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.